Initial Management of Acute Limb Ischemia

Immediate Clinical Assessment and Management

The European Society of Cardiology recommends immediate initiation of anticoagulation with intravenous unfractionated heparin, unless contraindicated, and provision of analgesia, all within minutes of diagnosis 1, 2, 3.
The American College of Cardiology suggests rapidly categorizing limb viability using the Rutherford Classification to determine urgency of intervention 3.
For Category IIa (marginally threatened) limbs, urgent revascularization within hours is recommended, with a strength of evidence classified as Class I 1, 2, 3.
The American Heart Association recommends providing adequate analgesia for ischemic pain control as soon as possible, with a strength of evidence classified as Class I 1, 2.

The American College of Radiology suggests that the choice and timing of imaging depends entirely on limb category, with Category IIb or III limbs requiring emergency revascularization within 4-6 hours 6, 1, 2.
For Category I or IIa limbs, imaging such as digital subtraction angiography (DSA), CT angiography, or duplex ultrasound can be used to guide treatment strategy, with a strength of evidence classified as Class IIa 6, 8, 4.

The European Society of Cardiology recommends emergency revascularization within 4-6 hours for Category IIb (immediately threatened) limbs, with a strength of evidence classified as Class I 1, 2, 3.
For Category IIa (marginally threatened) limbs, revascularization within hours of initial imaging is recommended on a case-by-case basis, with a strength of evidence classified as Class IIa 1, 2.
The American College of Cardiology suggests that treatment modality selection depends on symptom duration and local expertise, with catheter-based thrombolysis recommended for symptom duration <14 days (Class I recommendation) 8, 3.

The European Society of Cardiology recommends monitoring for compartment syndrome after revascularization and performing fasciotomy if indicated, with a strength of evidence classified as Class I 1, 2.
The American Heart Association suggests assessing clinical and hemodynamic success following revascularization to ensure adequate restoration of perfusion, with a strength of evidence classified as Class I 1, 2.

The American College of Cardiology recommends obtaining a comprehensive medical history to determine the cause of thrombosis and/or embolization, including Holter-ECG and echocardiogram to evaluate for cardiac embolic source 1, 2, 4.
The European Society of Cardiology suggests considering prothrombotic syndromes (antiphospholipid syndrome, vasculitis) if clinically suspected, with a strength of evidence classified as Class IIb 2.